Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes

Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes: A Randomized, Crossover Clinical Trial

The purpose of this study is to evaluate the effect of medically-tailored meal delivery (10 meals per week for 3 months) on glycemic control in diabetic patients.

Inclusion Criteria:

• Adult men and women with non-insulin dependent diabetes.
• Ages 25 to 75 years.
• Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%.
• Stabilized patients on oral hypoglycemic agents for one month or longer prior to starting the study and a hemoglobin A1C between 7.5% - 13%.

Exclusion Criteria:

• Insulin use.
• Substance abuse.
• Any documented medical problem that would inhibit full participation in the study.
• BMI less than 25 or great than 40.
• Vegans or Vegetarians
• Individuals with food allergies.
• Individuals currently on a commercial weight loss or diet program.